Trial Profile
Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue [EXTENSION OF 700012063]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia; Prostate cancer
- Focus Pharmacodynamics
- 01 Oct 2020 Status changed from suspended to completed.
- 17 Apr 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 17 Apr 2019 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.